This Cuban lung cancer drug is giving some U.S. patients hope


CIMAvax, a new lung cancer treatment based in Cuba, has proved to stop and reduce the growth of tumors. Although it's not FDA regulated, many Americans are turning to the therapeutic drug in hopes of reducing the effects of cancer.

Related Stories